You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Head and neck squamous cell carcinomas

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Needs and Preferences of Patients With Head-neck Cutaneous SCC

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +10 more
  • Regular care with additional administration of a semi-structured interview
  • Maastricht, Netherlands
    Maastricht University Medical Center+
Sep 13, 2023

Stage T3 Squamous Cell Carcinomas of the Scalp

Active, not recruiting
  • Squamous Cell Carcinoma
  • +2 more
    • Maastricht, Netherlands
      Ellen Oyen
    Aug 3, 2023

    Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 25, 2023

    Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)

    Recruiting
    • Squamous Cell Carcinoma
    • Head and Neck Cancer
    • Intensity-modulated radiotherapy
    • Magnetic Resonance Guidance
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 13, 2023

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +3 more
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    May 17, 2023

    Head-and-neck Squamous Cell Carcinoma Trial in Germany (De-escalation radio(chemo)therapy - Level 1, De-escalation

    Recruiting
    • Head-and-neck Squamous Cell Carcinoma
    • De-escalation radio(chemo)therapy - Level 1
    • +2 more
    • Freiburg, Baden-Wuerttemberg, Germany
    • +9 more
    Aug 2, 2022

    Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinomas
    • Tislelizumab + Dasatinib + Quercetin
    • surgery
    • (no location specified)
    Feb 2, 2023

    Squamous Cell Carcinoma of Head and Neck, Chemo Induced Nausea and Vomiting Trial (nurse-led standardized intervention)

    Not yet recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Chemotherapy Induced Nausea and Vomiting
    • nurse-led standardized intervention
    • (no location specified)
    Mar 29, 2023

    Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Malignant Solid Neoplasm
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 31, 2022

    Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial in Madison (Cetuximab, Imatinib)

    Recruiting
    • Head and Neck Cancer
    • Squamous Cell Carcinoma of Head and Neck
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Apr 24, 2023

    Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)

    Completed
    • Squamous Cell Carcinoma of Head and Neck
    • sEphB4-HSA with chemotherapy
    • +2 more
    • Aurora, Colorado
      University of Colorado Hospital
    Dec 9, 2022

    Head and Neck Squamous Cell Carcinomas Trial in Guanzhou (drug, procedure, radiation)

    Recruiting
    • Head and Neck Squamous Cell Carcinomas
    • Guanzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Oct 28, 2022

    Squamous Cell Carcinomas of the Head and Neck Trial in Taipei county (Fucoidan, Placebo( Potato starch))

    Recruiting
    • Squamous Cell Carcinomas of the Head and Neck
    • Fucoidan
    • Placebo( Potato starch)
    • Taipei county, Taiwan
      National Taiwan University Hospital
    Mar 14, 2022

    Decisional Conflicts, Health-related QoL and Satisfaction With

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +9 more
    • Regular care with additionally administration of questionnaires
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Jul 28, 2022

    Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))

    Active, not recruiting
    • Squamous Cell Carcinoma of the Head and Neck
    • Cisplatin
    • Stereotactic Body Radiation Therapy (SBRT)
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Mar 22, 2022

    Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma Trial in Edmonton, London, Montréal (SBRT, Durvalumab,

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Metastatic Squamous Cell Carcinoma
    • SBRT
    • +2 more
    • Edmonton, Alberta, Canada
    • +2 more
    Mar 14, 2022

    Head and Neck Tumors, Swallowing Sparing IMRT Trial in Jhajjar (Swallowing and submandibular sparing IMRT)

    Recruiting
    • Head and Neck Neoplasms
    • Swallowing Sparing IMRT
    • Swallowing and submandibular sparing IMRT
    • Jhajjar, Haryana, India
      Nci, Aiims
    Jan 17, 2022

    Head Neck Cancer Trial in Houston (drug, other, behavioral)

    Active, not recruiting
    • Head and Neck Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 31, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Belgium (Dose de-escalation and / or Volume de-escalation)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Dose de-escalation and / or Volume de-escalation
    • Brussel, Belgium
    • +3 more
    Jan 25, 2022

    Head and Neck Squamous Cell Carcinomas Trial in Guangzhou (Consolidation Toripalimab)

    Recruiting
    • Head and Neck Squamous Cell Carcinomas
    • Consolidation Toripalimab
    • Guangzhou, Guangdong, China
    • +1 more
    Oct 2, 2021

    Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Seattle (biological,

    Terminated
    • Metastatic Head and Neck Squamous Cell Carcinoma
    • Recurrent Head and Neck Squamous Cell Carcinoma
    • Durvalumab
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 23, 2022

    HNSCC Trial in Houston (Bimiralisib)

    Terminated
    Has Results
    • HNSCC
    • Houston, Texas
      M.D. Anderson Cancer Center
    Dec 22, 2021

    Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

    Recruiting
    • Advanced Solid Tumors
    • +5 more
    • Scottsdale, Arizona
    • +7 more
    Jan 23, 2023

    Squamous Cell Carcinoma of the Oropharynx Trial in United States (Radiation Therapy)

    Not yet recruiting
    • Squamous Cell Carcinoma of the Oropharynx
    • Radiation Therapy
    • Miami, Florida
    • +3 more
    Jul 22, 2023

    Head and Neck Carcinoma Trial in Cairo (Elective nodal de-escalation arm)

    Recruiting
    • Head and Neck Carcinoma
    • Elective nodal de-escalation arm
    • Cairo, Egypt
      National Cancer Institute
    Dec 6, 2022